Why Anheuser-Busch Is Still a Buy Even Though People Are Drinking Less

Anheuser-Busch InBev reported Q1 2026 revenue growth of 5.8% year over year, with underlying EPS up more than 20% as premium products, no-alcohol beer, and Beyond Beer drove performance. No-alcohol beer sales rose 27% and Beyond Beer grew 37%, helping offset a broader decline in global alcohol consumption. The article argues the stock remains reasonably valued and up 25% in 2026, though the piece is more commentary than a fresh market-moving catalyst.

Analysis

BUD is acting like a pricing-and-mix story, not a volume story, and that matters for durability. In a shrinking category, the winners are the firms with the strongest brand architecture and route-to-market leverage, because they can harvest margin from premium labels while low-end volume leaks to private label and local incumbents. The second-order effect is that supplier and distributor economics should improve for the best-positioned global players even if headline consumption keeps drifting down.

The market may still be underestimating how much of this is a portfolio shift rather than a cyclical bounce. No-alcohol and beyond-beer are small today, but they can extend shelf-space relevance and improve household penetration without relying on traditional occasion consumption; that creates optionality if younger cohorts continue to reduce alcohol frequency. The key question is whether this is a re-rating from temporary mix gains or a multi-year compounding path similar to what premium spirits achieved in earlier cycles.

The main risk is that premiumization is not infinitely elastic: if real incomes soften, consumers usually trade down first in discretionary beverage baskets. That would pressure the premium SKU mix over the next 2-6 quarters and could expose the stock’s recent run-up if investors have extrapolated too aggressively. STZ looks like the cleaner relative beneficiary if the category stays premium-led, but BUD’s broader scale gives it more operating leverage if the current demand regime persists.

Contrarian view: consensus is focused on structural alcohol decline, but the more important variable may be share shift within the category. If the total pie is modestly shrinking yet BUD keeps taking mix, the stock can work despite negative macro headlines; the surprise would be not top-line erosion, but sustained margin expansion. The setup favors owning the relative winners of premiumization while fading any short thesis based solely on aggregate liters-per-capita data.

Key Decisions for Investors

• Go long BUD on pullbacks over the next 2-4 weeks; treat the 25% YTD move as a momentum confirmation, but size for a 10-15% downside if premium mix slows or guidance implies elasticity pressure.
• Pair trade: long BUD / short a broad consumer staples basket over 1-3 months to isolate pricing power and category share gains; risk/reward improves if staples multiples compress while BUD continues to rerate on margin expansion.
• Prefer STZ over BUD on a relative basis for 3-6 months: if premiumization is the core theme, STZ offers cleaner U.S.-centric execution and less exposure to secular beer decline; use BUD as the hedge leg.
• If entering new longs, use call spreads rather than stock in BUD for the next earnings cycle: premiumization should support upside, but the stock can de-rate quickly if investors start pricing in slowing consumer demand.
• Set a tactical stop if no-alcohol/beyond-beer momentum decelerates for two consecutive quarters; that would suggest the mix shift is maturing and the current multiple expansion is vulnerable.